The clinical manifestations and survival of systemic lupus erythematosus patients in Turkey: report from two centers

Pamuk O. N., Akbay F. G., Doenmez S., Yilmaz N., Calayir G. B., Yavuz S.

LUPUS, cilt.22, sa.13, ss.1416-1424, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 22 Sayı: 13
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1177/0961203313499956
  • Dergi Adı: LUPUS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1416-1424
  • Anahtar Kelimeler: Systemic lupus erythematosus, survival, prognosis, nephritis, PRIMARY ANTIPHOSPHOLIPID SYNDROME, ACCELERATED ATHEROSCLEROSIS, REVISED CRITERIA, MORTALITY, CLASSIFICATION, POPULATION, PREVALENCE, INDEX, RACE, SLE
  • Marmara Üniversitesi Adresli: Evet

Özet

Background Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with a variety of clinical features. Survival has become longer as a result of better treatment modalities and better supportive care. There is no information on survival of SLE patients in Turkey. We evaluated clinical features and survival in SLE patients in two rheumatology departments.